Adaptive Biotechnologies (ADPT) Net Cash Flow Growth (5y) (2023 - 2026)
Adaptive Biotechnologies (ADPT) Net Cash Flow Growth (5y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | Adaptive Biotechnologies | 3.80 Bn | 3.58 Bn | 52.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.36% |
| Dec 31, 2025 | 15.34% |
| Sep 30, 2025 | -38.23% |
| Jun 30, 2025 | -15.43% |
| Mar 31, 2025 | -53.44% |
| Dec 31, 2024 | -14.73% |
| Sep 30, 2024 | -22.52% |
| Jun 30, 2024 | 28.92% |
| Mar 31, 2024 | -35.66% |
| Dec 31, 2023 | -24.99% |
| Sep 30, 2023 | -25.88% |